AAAAAA

   
Results: 1-18 |
Results: 18
Beneficial effects of ramipril on left ventricular end-diastolic and end-systolic volume indexes after uncomplicated invasive revascularization are associated with a reduction in cardiac events in patients with moderately impaired left ventricular function and no clinical heart failure
Authors: Kjoller-Hansen, L Steffensen, R Grande, P
Citation: L. Kjoller-hansen et al., Beneficial effects of ramipril on left ventricular end-diastolic and end-systolic volume indexes after uncomplicated invasive revascularization are associated with a reduction in cardiac events in patients with moderately impaired left ventricular function and no clinical heart failure, J AM COL C, 37(5), 2001, pp. 1214-1220
Clinical significance of abnormal T waves in patients with non-ST-segment elevation acute coronary syndromes
Authors: Jacobsen, MD Wagner, GS Holmvang, L Macfarlane, PW Naslund, U Grande, P Clemmensen, P
Citation: Md. Jacobsen et al., Clinical significance of abnormal T waves in patients with non-ST-segment elevation acute coronary syndromes, AM J CARD, 88(11), 2001, pp. 1225-1229
Contrast echocardiography for detection of pulmonary arteriovenous malformations
Authors: Nanthakumar, K Graham, AT Robinson, TI Grande, P Pugash, RA Clarke, JA Hutchison, SJ Mandzia, JL Hyland, RH Faughnan, ME
Citation: K. Nanthakumar et al., Contrast echocardiography for detection of pulmonary arteriovenous malformations, AM HEART J, 141(2), 2001, pp. 243-246
Health related quality of life after conservative or invasive treatment ofinducible postinfarction ischaemia
Authors: Mortensen, OS Madsen, JK Haghfelt, T Grande, P Saunamaki, K Haunso, S Hjelms, E Arendrup, H
Citation: Os. Mortensen et al., Health related quality of life after conservative or invasive treatment ofinducible postinfarction ischaemia, HEART, 84(5), 2000, pp. 535-540
The angiotensin-converting enzyme inhibition post revascularization study (APRES)
Authors: Kjoller-Hansen, L Steffensen, R Grande, P
Citation: L. Kjoller-hansen et al., The angiotensin-converting enzyme inhibition post revascularization study (APRES), J AM COL C, 35(4), 2000, pp. 881-888
Very early diagnosis and risk stratification of patients admitted with suspected acute myocardial infarction by the combined evaluation of a single serum value of cardiac troponin-T, myoglobin, and creatine kinase MBmass
Authors: Jurlander, B Clemmensen, P Wagner, GS Grande, P
Citation: B. Jurlander et al., Very early diagnosis and risk stratification of patients admitted with suspected acute myocardial infarction by the combined evaluation of a single serum value of cardiac troponin-T, myoglobin, and creatine kinase MBmass, EUR HEART J, 21(5), 2000, pp. 382-389
Intravenous NPA for the treatment of infarcting myocardium early - InTIME-II, a double-blind comparison of single-bolus lanoteplase vs accelerated alteplase for the treatment of patients with acute myocardial infarction
Authors: Braunwald, E Neuhaus, KL Antman, E Chew, P Skene, A Wilcox, R Ambrosioni, E Anderson, J Apetrei, E Bata, I Carrageta, M Col, J Dalby, A Davies, R Deckers, J Eichman, D Grande, P Greene, R Gurfinkel, E Heikkila, J Henry, T Hillis, D Hochman, J Huber, K Kostis, J Klinke, P Lopez-Sendon, J McKendall, G Moller, B Moore, P Morris, A Mueller, H Ostor, E Oto, A Ruda, M Sadowski, Z Schweiger, M Sequeira, R Shah, P Shannon, R Smith, B Sobel, B Steingart, R Tebbe, U Toman, J Traboulsi, M Vahanian, A Warnica, JW Willerson, J Deitchman, D Davidson, L Folgia, T Foxley, A Goodman, J Hauck, C Henry, D McCabe, C Pangerl, A Thomson, A Wagner, M Kennedy, JW Cairns, J DeMets, D Julian, D Simoons, M Charlesworth, A Henry, D Skene, A Easton, JD Ferbert, A Feske, S Kuhn, P Moseley, J Rogg, JM Reichmann, H Sloan, M von Kummer, R Zamani, A Antman, E Coulter, S Giugliano, R Wilcox, R
Citation: E. Braunwald et al., Intravenous NPA for the treatment of infarcting myocardium early - InTIME-II, a double-blind comparison of single-bolus lanoteplase vs accelerated alteplase for the treatment of patients with acute myocardial infarction, EUR HEART J, 21(24), 2000, pp. 2005-2013
Comparison of sibrafiban with aspirin for prevention of cardiovascular events after acute coronary syndromes: a randomised trial
Authors: Topol, CE Califf, RM Simes, RJ Van de Werf, F Diaz, R Paolasso, E Aylward, PE Keech, A Klein, W Piegas, L Tomov, I Armstrong, PW Widimsky, P Grande, P Halinen, M Vahanian, A Neuhaus, K Dimas, AP Preda, I Kristinsson, A Tzivoni, D Ardissino, D White, HD Madsen, S Sugrue, D Sadowski, Z Seabra-Gomes, R Apetrei, E Dalby, A Betriu, A Pfisterer, M Verheugt, F Fox, K Bates, ER Gibler, WB Granger, CB Harrington, RA Hochman, JS Holmes, DR Kleiman, NS Lee, KL Moliterno, DJ Newby, LK Ohman, EM Califf, R Newby, K Zillman, L Lee, K Lemons, P McCourt, B Campbell, C Tardiff, B Snapp, J Bassett, K Hodgson, P Hannan, K Kandzari, L Hawkins, S Hinman-Smith, E McDougal, M Raffetto, K Thompson, D Wehrle, T Ange, C Brown, R Grissom, G Heuckel, M McCall, J Pennachi, W Spychala, M Veasey, S Pullium, M Journey, T Quintero, K Mark, D Davidson-Ray, L Diner, L Nelson, C Sowers, C Webb, G Young, M Bhapkar, M Pacchiana, C Sparapani, R Tuttle, R Weaver, D Borzak, S Douthat, L Topol, E Moliterno, D Konczos, L Baishnab, R Baishnab, R Bakos, A Blashford, L Bratsch, J Brown, K Cadorini, E Carlson, J Clemmons, P DelValle, M Drabik, M Fu, G Gates, K Gibson, Y Heil, L Hill, N Klancar, R McHale, B Montague, E Pasca, N Pergi, L Randall, R Rosso, R Sankovich, K Smith, D Wisniewski, L Witkowski, M Zovkic, V Alexander, K Bhatt, D Brener, S Campbell, L Cho, L Cole, C Deedy, M Foody, J Gassler, J Ghaffari, S Haas, G Kapadia, S Lauer, M Lauer, MS Lincoff, M Lutton, S Marso, S Mukherjee, D Patel, V Penn, M Robbins, M Roe, M Sila, C Thamilarasan, M Wagner, G Armstrong, P Bestilny, S Van de Werf, F Budts, W Graux, S Luyten, A Simes, J Keech, A Kava, M Bower, T Chan, S Crampton, L Monro, C Nayak, M Parente, G Riley, V Wilton, D Aylward, P Dolan, S Thomas, C White, H Scott, M Frye, R Alpert, J Bertrand, M Ryan, T Fisher, L Asarch, L Smith, M Lim, L Bokslag, M Chiu, P Chung, J Collins, S Dougherty, C Guimaraes, D Hakim, Z Mathieson, J Montgomery, L Novotny, B Steiner, B Wittke, B
Citation: Ce. Topol et al., Comparison of sibrafiban with aspirin for prevention of cardiovascular events after acute coronary syndromes: a randomised trial, LANCET, 355(9201), 2000, pp. 337-345
Evolving non-Q wave versus Q wave myocardial infarction after thrombolysis: A high risk population benefitting from early revascularization. A DANAMIsubstudy
Authors: Clemmensen, P Grande, P Nielsen, WB Madsen, JK Saunamaki, K Kassis, E Thayssen, P Eriksen, U Rasmussen, K Haunso, S Nielsen, TT Haghfelt, T Wagner, GS
Citation: P. Clemmensen et al., Evolving non-Q wave versus Q wave myocardial infarction after thrombolysis: A high risk population benefitting from early revascularization. A DANAMIsubstudy, J ELCARDIOL, 33, 2000, pp. 65-66
Coronary angiographic findings and troponin T in patients with unstable angina pectoris
Authors: Jurlander, B Farhi, ER Banas, JJ Keany, CM Balu, D Grande, P Ellis, AK
Citation: B. Jurlander et al., Coronary angiographic findings and troponin T in patients with unstable angina pectoris, AM J CARD, 85(7), 2000, pp. 810-814
Long-term low-molecular-mass heparin in unstable coronary-artery disease: FRISC II prospective randomised multicentre study
Authors: Wallentin, L Swahn, E Kontny, F Husted, S Lagerqvist, B Stahle, E Nielsen, JD Dellborg, M Geiran, O Grande, P Hulting, J Kyst-Madsen, J Nordrehaug, JE Naslund, U Pilegaard, H Rollag, A Nielsen, TT Saetre, H Siegbahn, A Ohlin, H Arbeus, M Bylund, H Ekstrom, SL Eriksson, GP Geiran, O Holmgren, A Kellerth, T Kyst-Madsen, J Lindblom, D Lindvall, B Nordrehaug, J Pilegaard, H Radegran, K Sjogren, I Stenport, G Stahl, E Svane, B Svedjeholm, R Toftegaard-Nielsen, T Hassan, SY Naslund, U Persson, S Jacobsson, KA Thygesen, K von der Lippe, G Julian, D Bertrand, M Wedel, H Andren, B Diderholm, E Frostfeldt, G Jernberg, T Dellborg, M Abrahamsson, P Lindahl, B Jernberg, T Siegbahn, A Venge, P Swahn, E Janzon, M Logander, E Svensson, E Lindstrom, G Alsjo, G Gulin, M Setterberg, G Wikstrom, L Andersen, IM Seim, T
Citation: L. Wallentin et al., Long-term low-molecular-mass heparin in unstable coronary-artery disease: FRISC II prospective randomised multicentre study, LANCET, 354(9180), 1999, pp. 701-707
Invasive compared with non-invasive treatment in unstable coronary-artery disease: FRISC II prospective randomised multicentre study
Authors: Wallentin, L Swahn, E Kontny, F Husted, S Lagerqvist, B Stahle, E Nielsen, JD Dellborg, M Geiran, O Grande, P Hulting, J Kyst-Madsen, J Nordrehaug, JE Naslund, U Pilegaard, H Rollag, A Nielsen, TT Saetre, H Siegbahn, A Ohlin, H Lagerqvist, B Arbeus, M Bylund, H Ekstrom, L Eriksson, P Geiran, O Holmgren, A Kellerth, T Kyst-Madsen, J Lindblom, D Lindvall, B Nordrehaug, J Pilegaard, H Radegran, K Sjogren, I Stenport, G Stahl, E Svane, B Svedjeholm, R Toftegaard-Nielsen, T Hassan, SY Naslund, U Persson, S Jacobsson, KA Thygesen, K von der Lippe, G Julian, D Bertrand, M Wedel, H Andren, B Diderholm, E Frostfeldt, G Jernberg, T Dellborg, M Abrahamsson, P Lindahl, B Jernberg, T Siegbahn, A Venge, P Swahn, E Janzon, M Logander, E Svensson, E Lindstrom, G Alsjo, G Gulin, M Setterberg, G Wikstrom, L M-Andersen, I Seim, T
Citation: L. Wallentin et al., Invasive compared with non-invasive treatment in unstable coronary-artery disease: FRISC II prospective randomised multicentre study, LANCET, 354(9180), 1999, pp. 708-715
"Add-on" research in clinical trials: Are we asking the right questions?
Authors: Clemmensen, P Holmvang, L Grande, P Wagner, GS
Citation: P. Clemmensen et al., "Add-on" research in clinical trials: Are we asking the right questions?, J ELCARDIOL, 32, 1999, pp. 108-110
Revascularization after myocardial infarction - Reply
Authors: Madsen, JK Grande, P
Citation: Jk. Madsen et P. Grande, Revascularization after myocardial infarction - Reply, CIRCULATION, 99(9), 1999, pp. 1273-1273
Relative contributions of a single-admission 12-lead electrocardiogram andearly 24-hour continuous electrocardiographic monitoring for early risk stratification in patients with unstable coronary artery disease
Authors: Holmvang, L Andersen, K Dellborg, M Clemmensen, P Wagner, G Grande, P Abrahamsson, P
Citation: L. Holmvang et al., Relative contributions of a single-admission 12-lead electrocardiogram andearly 24-hour continuous electrocardiographic monitoring for early risk stratification in patients with unstable coronary artery disease, AM J CARD, 83(5), 1999, pp. 667-674
Effects of revascularization after first acute myocardial infarction on the evolution of QRS complex changes (the DANAMI trial)
Authors: Lyck, F Holmvang, L Grande, P Madsen, JK Wagner, GS Clemmensen, P
Citation: F. Lyck et al., Effects of revascularization after first acute myocardial infarction on the evolution of QRS complex changes (the DANAMI trial), AM J CARD, 83(4), 1999, pp. 488-492
Admission standard electrocardiogram for early risk stratification in patients with unstable coronary artery disease not eligible for acute revascularization therapy: A TRIM substudy
Authors: Holmvang, L Clemmensen, P Wagner, G Grande, P
Citation: L. Holmvang et al., Admission standard electrocardiogram for early risk stratification in patients with unstable coronary artery disease not eligible for acute revascularization therapy: A TRIM substudy, AM HEART J, 137(1), 1999, pp. 24-33
Differences between local investigator and core-laboratory interpretation of the admission electrocardiogram in patients with unstable angina pectoris or non-Q myocardial infarction (A thrombin inhibition in myocardial ischemia [TRIM] substudy)
Authors: Holmvang, L Hasbak, P Clemmensen, P Wagner, G Grande, P
Citation: L. Holmvang et al., Differences between local investigator and core-laboratory interpretation of the admission electrocardiogram in patients with unstable angina pectoris or non-Q myocardial infarction (A thrombin inhibition in myocardial ischemia [TRIM] substudy), J ELCARDIOL, 31, 1998, pp. 126-127
Risultati: 1-18 |